DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Read More…
Industry, Sector and Symbol
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
Phone720-631-2100
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$11.40 billion
Profitability
Miscellaneous
Employees77,700
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable
Davita (NYSE:DVA) Frequently Asked Questions
What is Davita's stock symbol?
Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."
How will Davita's stock buyback program work?
Davita declared that its board has authorized a stock buyback program on Wednesday, October 11th 2017, which allows the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company's management believes its stock is undervalued.
How were Davita's earnings last quarter?
Davita Inc (NYSE:DVA) announced its earnings results on Thursday, August, 1st. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.10 by $0.12. The company had revenue of $2.84 billion for the quarter, compared to analysts' expectations of $2.86 billion. Davita had a net margin of 1.21% and a return on equity of 14.67%. The business's revenue for the quarter was down 1.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.05 earnings per share. View Davita's Earnings History.
When is Davita's next earnings date?
What price target have analysts set for DVA?
8 equities research analysts have issued 12 month target prices for Davita's stock. Their predictions range from $60.00 to $70.00. On average, they anticipate Davita's share price to reach $65.3486 in the next year. This suggests a possible upside of 6.0% from the stock's current price. View Analyst Price Targets for Davita.
What is the consensus analysts' recommendation for Davita?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Davita.
Has Davita been receiving favorable news coverage?
News headlines about DVA stock have trended negative recently, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Davita earned a daily sentiment score of -2.9 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Davita.
Are investors shorting Davita?
Davita saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 14,719,000 shares, an increase of 62.2% from the July 31st total of 9,074,800 shares. Based on an average trading volume of 2,900,000 shares, the short-interest ratio is currently 5.1 days. Currently, 9.4% of the shares of the stock are short sold. View Davita's Current Options Chain.
Who are some of Davita's key competitors?
What other stocks do shareholders of Davita own?
Who are Davita's key executives?
Davita's management team includes the folowing people:
- Mr. Kent J. Thiry, Chairman & CEO (Age 63)
- Mr. Joel Ackerman, Chief Financial Officer (Age 54)
- Mr. James K. Hilger, Chief Accounting Officer (Age 57)
- Ms. Kathleen Alyce Waters, Chief Legal Officer (Age 51)
- Mr. Javier J. Rodriguez, Chief Exec. Officer of DaVita Kidney Care (Age 48)
Who are Davita's major shareholders?
Davita's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.52%), BlackRock Inc. (7.60%), BlackRock Inc. (7.60%), Par Capital Management Inc. (2.59%), Invesco Ltd. (2.28%) and Viking Global Investors LP (1.81%). Company insiders that own Davita stock include Charles Berg, James K Hilger, Javier Rodriguez, Kent J Thiry, Leanne M Zumwalt, Pamela M Arway and William L Roper. View Institutional Ownership Trends for Davita.
Which institutional investors are selling Davita stock?
DVA stock was sold by a variety of institutional investors in the last quarter, including TIG Advisors LLC, TIG Advisors LLC, AQR Capital Management LLC, Price T Rowe Associates Inc. MD, BlackRock Inc., BlackRock Inc., First Trust Advisors LP and Schroder Investment Management Group. View Insider Buying and Selling for Davita.
Which institutional investors are buying Davita stock?
DVA stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., Par Capital Management Inc., Pictet Asset Management Ltd., DekaBank Deutsche Girozentrale, Camber Capital Management LP, Nuveen Asset Management LLC, Tavio Capital LLC and SkyTop Capital Management LLC. View Insider Buying and Selling for Davita.
How do I buy shares of Davita?
Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Davita's stock price today?
One share of DVA stock can currently be purchased for approximately $61.65.
How big of a company is Davita?
Davita has a market capitalization of $9.88 billion and generates $11.40 billion in revenue each year. The company earns $159.39 million in net income (profit) each year or $3.57 on an earnings per share basis. Davita employs 77,700 workers across the globe.View Additional Information About Davita.
What is Davita's official website?
How can I contact Davita?
Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]
MarketBeat Community Rating for Davita (NYSE DVA)
MarketBeat's community ratings are surveys of what our community members think about Davita and other stocks. Vote "Outperform" if you believe DVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DVA will underperform the S&P 500 over the long term. You may vote once every thirty days.
